Director for Clinical Trials, Division of Gynecologic Oncology
American Board of Obstetrics and Gynecology - Diplomate
American Board of Obstetrics and Gynecology, Sub-specialty in Gynecologic Oncology - Diplomate
Division of Gynecologic Oncology
|Academic Phone:||415-885-7561 /415-885-7204|
Dr. Edwin Alexander Alvarez is a board certified gynecologic oncologist. He specializes in gynecologic malignancies at the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center. His primary focus is the surgical and medical treatment of ovarian cancer, cervical cancer, endometrial cancer and other malignancies of the female reproductive system. Dr. Alvarez performs both open and minimally invasive gynecologic oncology and complicated gynecologic surgery.
As Director of Clinical Trials for the Division, Dr. Alvarez is involved with NRG Oncology, the NCI sponsored cooperative group for oncology clinical trials. Before coming to UCSF, Dr. Alvarez was the director for chemotherapy services for gynecologic malignancies at UC Davis.
Dr. Alvarez has a strong commitment to teaching of medical students, residents and fellows. He is fluent in Spanish.
Dr. Alvarez has made on-going contributions to diversity starting in medical school when he became the Co-chair for the Chicano/Latino Medical Student Association (CMSA) UC San Diego School of Medicine branch. He participated in outreach visits to local high schools with at-risk youth, and organized a fund-raiser for a scholarship. His contributions continued as an Assistant Professor at UC San Diego where I initiated a culturally sensitive mostly latino indigent care clinic in Gynecologic Oncology. While at UC Davis he mentored latina medical students who have successfully obtained residency positions at UC Davis in Obstetrics and Gynecology.
|Year||Institution & Location||Degree||Field of Study|
|1995||University of California, Berkeley||B.A.||Sociology|
|2000||University of California, San Diego||M.D.||Medicine|
|2004||University of Southern California, Keck School of Medicine||Residency||
Obstetrics & Gynecology
|2007||University of Miami, Miller School of Medicine||Fellowship||
Achievements & Recognition
|2004||Research award, University of Southern California Ob/Gyn 19th annual Senior Research Day|
|2007||Women’s Reproductive Health Research Award (NIH K12) PI: Tom Moore, MD K12 HD001259-12; University of California, San Diego|
1. A phase I study of docetaxel as a radiosensitizer for locally advanced squamous cell cervical cancer. Alvarez EA, Wolfson AH, Pearson JM, Crisp M, Mendez LE, Lambrou NC, Lucci JA 3rd. Gynecologic Oncology. 2009 May; 113(2): 195-9.
2. Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo. Chen Y, Alvarez EA, Azzam D, Wander SA, Guggisberg N, Jordà M, Ju Z, Hennessy BT, Slingerland JM. Breast Cancer Res Treat. 2011 Jul; 128 (1): 69-78.
3. Ureteral-arterial fistula: A case report and review of the literature. McCullough MC, Oh EE, Lucci JA 3rd, Alvarez EA. Journal of Obstetrics and Gynaecology. 2012 Oct; 32(7): 617-20.
4. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Shang X, Lin X, Alvarez E, Manorek G, Howell SB. Neoplasia. 2012 Oct;14(10):974-85
5. Phase II Evaluation of Combination Bevacizumab and Temsirolimus (CCI-779) in the Treatment of Recurrent or Persistent Endometrial Carcinoma: a Gynecologic Oncology Group study. Alvarez EA, Brady WE, Walker JL, Rotmensch J, Zhou XC, Kendrick JE, Yamada SD, Schilder JM, Cohn DE, Harrison CR, Moore KN, Aghajanian C. Gynecologic Oncology. 2013 Apr;129(1):22-7